USA - NASDAQ:LFMD - US53216B1044 - Common Stock
The current stock price of LFMD is 6.3 USD. In the past month the price decreased by -2.02%. In the past year, price increased by 46.85%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 39.33 | 48.03B | ||
| DOCS | DOXIMITY INC-CLASS A | 44.86 | 12.52B | ||
| WAY | WAYSTAR HOLDING CORP | 35.11 | 7.44B | ||
| HTFL | HEARTFLOW INC | N/A | 3.16B | ||
| CERT | CERTARA INC | 25.84 | 2.03B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.67B | ||
| SDGR | SCHRODINGER INC | N/A | 1.66B | ||
| PHR | PHREESIA INC | N/A | 1.41B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 11.29 | 1.37B | ||
| CTEV | CLARITEV CORP | N/A | 1.15B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.07B | ||
| EVH | EVOLENT HEALTH INC - A | N/A | 917.75M |
LifeMD, Inc. is a telehealth company, which engages in offering a portfolio of direct-to-patient products and services. The company is headquartered in New York City, New York and currently employs 304 full-time employees. The company went IPO on 2001-07-11. The firm offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s and women’s health, weight management, and hormone therapy. The firm operates through two segments: Telehealth and WorkSimpli. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. WorkSimpli is a provider of workplace and document services for consumers, gig workers, and small businesses. The company operates brands including: PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild, a provider of digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses.
LIFEMD INC
236 Fifth Avenue, Suite 400
New York City NEW YORK 10022 US
CEO: Justin Schreiber
Employees: 306
Phone: 18663515907
LifeMD, Inc. is a telehealth company, which engages in offering a portfolio of direct-to-patient products and services. The company is headquartered in New York City, New York and currently employs 304 full-time employees. The company went IPO on 2001-07-11. The firm offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s and women’s health, weight management, and hormone therapy. The firm operates through two segments: Telehealth and WorkSimpli. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. WorkSimpli is a provider of workplace and document services for consumers, gig workers, and small businesses. The company operates brands including: PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild, a provider of digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses.
The current stock price of LFMD is 6.3 USD. The price increased by 1.12% in the last trading session.
LFMD does not pay a dividend.
LFMD has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
The Revenue of LIFEMD INC (LFMD) is expected to grow by 23.06% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
LIFEMD INC (LFMD) currently has 306 employees.
The outstanding short interest for LIFEMD INC (LFMD) is 11.45% of its float.
ChartMill assigns a technical rating of 1 / 10 to LFMD. When comparing the yearly performance of all stocks, LFMD turns out to be only a medium performer in the overall market: it outperformed 48.51% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to LFMD. LFMD has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months LFMD reported a non-GAAP Earnings per Share(EPS) of -0.21. The EPS increased by 70% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -12.28% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
15 analysts have analysed LFMD and the average price target is 13.13 USD. This implies a price increase of 108.45% is expected in the next year compared to the current price of 6.3.
For the next year, analysts expect an EPS growth of 74.18% and a revenue growth 23.06% for LFMD